Authors: Reiter RR, Sharma R, Castillo R, Marik PE, Rodriguez AD, Cardinali DP Abstract Two highly relevant studies related to SARS-CoV-2 and coronavirus disease (COVID-19) and supporting the use of melatonin to prevent and treat this serious infection were published recently. Campos-Codo and colleagues [1] documented experimentally their claim that drugs which specifically target [...]

Authors: Rattis BA, Ramos SG, Celes MR. PMID: PMC8138567 DOI: 10.3389/fphar.2021.675287 Abstract Coronavirus disease 2019 (COVID-19) is an infectious disease that rapidly spread throughout the world leading to high mortality rates. Despite the knowledge of previous diseases caused by viruses of the same family, such as MERS and SARS-CoV, management and treatment of patients with [...]

Authors: Rattis BA, Ramos SG, Celes MR PMID: 34025433 PMCID: PMC8138567 DOI: 10.3389/fphar.2021.675287 Abstract Coronavirus disease 2019 (COVID-19) is an infectious disease that rapidly spread throughout the world leading to high mortality rates. Despite the knowledge of previous diseases caused by viruses of the same family, such as MERS and SARS-CoV, management and treatment of [...]

Auhtors: H. Metabolical Abstract The New York Times bestselling author of Fat Chance explains the eight pathologies that underlie all chronic disease, documents how processed food has impacted them to ruin our health, economy, and environment over the past 50 years, and proposes an urgent manifesto and strategy to cure both us and the planet. [...]

Authors: Jeronimo CM, Farias ME, Almeida FF, Sampaio VS, Alexandre MA, Melo GC PMID: 32785710 PMCID: PMC7454320 DOI: 10.1093/cid/ciaa1177 Abstract Background: Steroid use for coronavirus disease 2019 (COVID-19) is based on the possible role of these drugs in mitigating the inflammatory response, mainly in the lungs, triggered by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). [...]

Authors: Mahmud R, Rahman M, Alam I, Ahmed KG, Kabir H, Sayeed SK et al. PMID: 33983065 PMCID: PMC8127799 DOI: 10.1177/03000605211013550 Abstract Objective: We evaluated whether ivermectin combined with doxycycline reduced the clinical recovery time in adults with COVID-19 infection. Methods: This was a randomized, blinded, placebo-controlled trial in patients with mild-to-moderate COVID-19 symptoms randomly [...]

Auhtors: Marton LT, Pescinini-e-Salzedas LM, Eduarda M, Camargo C, Barbalho SM, dos Santos Haber JF, et al. PMID: 34012421 PMCID: PMC8126655 DOI: 10.3389/fendo.2021.669448 Abstract Diabetes mellitus (DM) is an ensemble of metabolic conditions that have reached pandemic proportions worldwide. Pathology's multifactorial nature makes patient management, including lifelong drug therapy and lifestyle modification, extremely challenging. Currently, [...]

Authors: Rose J Abstract Following the global roll-out and administration of the Pfizer/BioNTech (BNT1 62b2) and Moderna (mRNA-1 273) COVID-1 9 vaccines 1 on December 1 7, 2020 in the United States, and of the Janssen COVID-1 9 Vaccine PF (produced by Johnson & Johnson) on April 1 st, 2021 , tens of thousands [...]

Authors: Janiri D, Carfi A, Kotzalidis GD, Bernabei R PMID: 33599709 PMCID: PMC7893542 DOI: 10.1001/jamapsychiatry.2021.0109 Abstract This cross-sectional study analyzes characteristics associated with posttraumatic stress disorder in patients after severe coronavirus disease 2019 (COVID-19). Keywords: COVID-19, PTSD, post traumatic stress disorder Source: https://pubmed.ncbi.nlm.nih.gov/33599709/ Archive: https://archive.is/xmUUh

Authors: Trahtemberg U, Fritzler MJ PMID: 33928414 PMCID: PMC8084710 DOI: 10.1007/s00134-021-06408-z Abstract Coronavirus disease 2019 (COVID-19) has similarities to systemic autoimmune conditions, including an association with increased incidence of autoantibodies, including those directed toward cytokines. However, reports to date lack longitudinal assessments and have inadequate controls (i.e., comparison to different severities within COVID-19 or to [...]